We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
-15.37%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$275M
AUM Growth
-$70.6M
Cap. Flow
-$17.2M
Cap. Flow %
-6.25%
Top 10 Hldgs %
93.23%
Holding
53
New
16
Increased
5
Reduced
4
Closed
26

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$12.2M
2
AMT icon
American Tower
AMT
+$3.76M
3
XENE icon
Xenon Pharmaceuticals
XENE
+$2.57M
4
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$2.47M
5
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$2.35M

Top Sells

Rank Stock Value
1
SEDG icon
SolarEdge
SEDG
+$6.45M
2
SWX icon
Southwest Gas
SWX
+$5.87M
3
FULC icon
Fulcrum Therapeutics
FULC
+$5.6M
4
CRBU icon
Caribou Biosciences
CRBU
+$4.32M
5
KALV
KalVista Pharmaceuticals
KALV
+$3.89M

Sector Composition

Rank Sector Weight
1 Healthcare 12.43%
2 Real Estate 1.96%
3 Consumer Staples 1.65%
4 Materials 0.96%
5 Utilities 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$655B
$226M 82.14%
1,196,400
+59,300
+5% +$12.2M
KDNY
2
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$4.2M 1.53%
240,000
+150,000
+167% +$2.35M
SLGC
3
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$4.18M 1.52%
925,000
+415,000
+81% +$2.47M
HYPR icon
4
Hyperfine
HYPR
$95.3M
$3.89M 1.41%
1,742,490
-12,548
-0.7% -$36.9K
AMT icon
5
American Tower
AMT
$77.7B
$3.83M 1.4%
+15,000
New +$3.76M
ACI icon
6
Albertsons Companies
ACI
$5.57B
$3.34M 1.22%
125,000
+65,000
+108% +$1.99M
CMPX icon
7
Compass Therapeutics
CMPX
$375M
$3.26M 1.19%
1,230,441
-39,770
-3% -$86.3K
DCGO icon
8
DocGo
DCGO
$62.2M
$2.75M 1%
385,058
-24,373
-6% -$178K
XENE icon
9
Xenon Pharmaceuticals
XENE
$6.36B
$2.59M 0.94%
+85,000
New +$2.57M
VIEW
10
DELISTED
View, Inc. Class A Common Stock
VIEW
$2.43M 0.88%
25,000
– –
ACLX
11
DELISTED
Arcellx
ACLX
$2.21M 0.8%
+122,129
New +$1.58M
DYN icon
12
Dyne Therapeutics
DYN
$4.24B
$2.19M 0.8%
319,536
+39,832
+14% +$274K
ANTX icon
13
AN2 Therapeutics
ANTX
$178M
$1.81M 0.66%
233,330
-200,000
-46% -$2.65M
CRNX icon
14
Crinetics Pharmaceuticals
CRNX
$8.87B
$1.77M 0.65%
+95,000
New +$1.9M
CYTK icon
15
Cytokinetics
CYTK
$10.9B
$1.77M 0.64%
+45,000
New +$1.81M
GLPI icon
16
Gaming and Leisure Properties
GLPI
$12.8B
$1.55M 0.57%
+33,908
New +$1.55M
EWCZ
17
DELISTED
European Wax Center
EWCZ
$1.18M 0.43%
+67,000
New +$1.71M
TSVT
18
DELISTED
2seventy bio
TSVT
$1.06M 0.38%
+80,000
New +$1.09M
MLTX icon
19
MoonLake Immunotherapeutics
MLTX
$1.69B
$1.05M 0.38%
+200,000
New +$1.26M
REVB icon
20
Revelation Biosciences
REVB
$4.14M
$907K 0.33%
4
– –
AXIA
21
AXIA Energia
AXIA
$22.9B
$887K 0.32%
+126,322
New +$852K
ACDC icon
22
ProFrac Holding
ACDC
$725M
$549K 0.2%
+30,000
New +$588K
DAWN
23
DELISTED
Day One Biopharmaceuticals
DAWN
$537K 0.2%
+30,000
New +$310K
LU icon
24
Lufax Holding
LU
$1.27B
$510K 0.19%
+21,250
New +$494K
ASPN icon
25
Aspen Aerogels
ASPN
$385M
$371K 0.14%
+37,500
New +$757K
1
2 3

Similar funds

EFIC
Eliot Finkel Investment Counsel Beverly Hills, California $184M AUM 33.43% 1-Year Est. Return
SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
AAM
Ameraudi Asset Management New York $184M AUM 15.4% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
KWM
KMT Wealth Management El Segundo, California $184M AUM 17.2% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Monashee Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Monashee Investment Management held 53 positions worth $275M, down 20% from $345M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Monashee Investment Management withdrew a net $17.2M in Q2 2022, closing 26 positions and reducing 4 holdings. Its most notable exit was SolarEdge, an estimated $6.45M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 16% a quarter earlier, followed by Real Estate and Consumer Staples.

Against the trend, Monashee Investment Management opened a new position in American Tower worth $3.83M.

  • Monashee Investment Management's largest Q2 2022 buy was American Tower: 15,000 shares worth $3.83M.
  • Monashee Investment Management added most to Vanguard Total Stock Market ETF in Q2 2022, an estimated $12.2M increase.
  • Monashee Investment Management's biggest Q2 2022 reduction was AN2 Therapeutics, cutting an estimated $2.65M.
  • Monashee Investment Management fully exited SolarEdge in Q2 2022, selling an estimated $6.45M.
  • Monashee Investment Management's ten largest holdings make up 93% of its $275M portfolio in Q2 2022.
  • Monashee Investment Management opened 16 new positions and closed 26 in Q2 2022.
  • Monashee Investment Management's portfolio value fell 20% quarter-over-quarter to $275M.

Based on Monashee Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.